ReviewFrontiers in nutrition2026
Plant-based dietary biomarkers: from discovery to validation using mass spectrometry-based metabolomics.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As diets shift globally toward plant-based foods, objective tools are needed to monitor intake and evaluate the resulting health outcomes. Biomarkers of dietary exposure offer complementary objective measurements for self-reported dietary assessment methods. Recent developments of mass spectrometry-based metabolomics have enabled the discovery of many emerging biomarkers for plant-based foods; yet a substantial gap remains between discovery and clinical application. This narrative review addresses the question: which plant-based food biomarkers are sufficiently validated for use in dietary exposure assessments, and which analytical and biological obstacles currently limit their application in population studies? Biomarkers reported in the literature were categorized as validated, emerging, or discovery-stage candidates. Analytical methodologies for biomarker quantification are also discussed, including high-resolution mass spectrometry platforms, and emerging techniques. Challenges identified in biomarker validation involve inter-individual metabolic variability, inadequate food specificity, and matrix effects in biological samples. Integration of foodomics databases with targeted validation studies potentially offers an efficient approach to speed up biomarker discovery. Multi-marker panels combining structurally different metabolites are promising for assessing complex plant-based dietary patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.